• serving others:

    LIFE. LEADERSHIP. LEGACY.

    "If you can't measure it,

    you can't improve it."

    -Peter Drucker

     

    INSPIRED BY: BOB BUFORD'S - "HALFTIME"

    Steve johandes' INTENTIONAL

    strategy TO live a 100X.LIFE

  • THE "WHY" OF 100X

    MY PERSONAL KPI'S

    "If you can't measure it, you can't improve it."

    “Management is doing things right; leadership is doing the right things.”

    - PETER DRUCKER

    Chair. 2 Groups.

    Members = 29.

    3 - Forbes "Small Giants"

    10 - WM Best & Brightest.

    CLIENTS = 37

    Companies served through my work.

    Client and 100X Press.

    boards = 4

    Assist in Board formation.

    Boards served = 6.

    family offices

    Legacy-driven.

    100-year vision.

    Facilitator: Family,

    Portfolio, and Next Gen.

    EMPLOYEES =10,000

    Impacted through the leaders I serve.

    VALUES

    Just begin. Be intentional.

    Stay relevant. Speak life.

    Blog and YouTube.

    ABOUT STEVE

    Serving others:

    Life, Leadership, Legacy.

    Entrepreneur, M&A, Value Creator, Board Member, Vistage Chair, Facilitator, Connector, Storyteller, Advocate.

  • STEVE JOHANDES' CLIENTS:

  • VIDEO STORYTELLING

    THE WHY, WHAT, AND HOW OF 100X.

    Always start with the Why! How I facilitate and think.

    WHY VISTAGE?

    What a Vistage Executive Peer Group feels like.

    100X Facilitation.

    Inside a real session. 8 hours in 6 min. Blurred.

  • ABOUT STEVE JOHANDES

    Serving others: Life leadership & legacy.

    (616) 403-2554 | Steve@100X.LIFE | WWW.100X.LIFE

    free content /  Thought Leadership

    entrepreneur

    Steve Johandes is a successful entrepreneur turned executive coach, Vistage Chair, Advisory Board Member and specializes in working with legacy driven Family Offices, PE and Venture Funds . He summarizes his multi-faceted 100X practice in a few simple words. “Working with leaders on life, leadership and legacy”. He serves 10,000 employees through the leaders he works with.

    A NEW JOURNEY

    Recently, Steve has started a new journey: Battling B-Mantle Cell Lymphoma (BMCL). Since his diagnosis, he has become part of MD Anderson’s moonshot program, on the disease; headed by Dr. Michael Wang.

    THE TRIAL

    He is participating in a Phase II clinical trial (Windows 2) that uses a combination of ibrutinib, rituximab, and venetoclax to create a chemo-free, immunotherapy based treatment. By using this method, the toxicity (and 12% secondary Leukemia risk) associated with the traditional treatments (front-line chemo / stem-cell transplant) are avoided.

    ADVOCATE - PAYING IT FORWARD

    Steve is thrilled to be a part of this groundbreaking study, and his goal is to be the first generation of early stage MCL patients to eradicate this disease. Following his mantra of life, leadership, and legacy, he has decided to use this experience to help others as a Cancer Advocate. Steve is happy to discuss, his journey and give advice for any patient navigating the medical system to finding best in class treatment options with any patient facing a life threatening diagnosis. Never settle!